- 10 years in the pharmaceutical industry
- Specialist in strategic regulatory guidance and analysis of FDA premarket processes
- Previous industry experience in regulatory policy development and business forecasting
Brian T. Corrigan joined Greenleaf in August 2014, following more than a decade of professional experience in the biopharmaceutical industry. Brian uses his in-depth understanding of the US healthcare system and the Food and Drug Administration’s (FDA) regulatory process to provide strategic and technical guidance to Greenleaf clients.
Before joining Greenleaf, Brian was a key member of the Government Affairs and Public Policy team at Vertex Pharmaceuticals, a global biotechnology company. While at Vertex, Brian led the development of federal policy strategies and worked closely with the company’s leadership to incorporate these strategies into the business planning and forecasting process. Brian also represented the company on industry trade association committees and was responsible for translating industry developments into actionable corporate initiatives.
Brian joined Vertex Pharmaceuticals from Astellas Pharma U.S., a top-20 global research-based biopharmaceutical company, where he worked on federal policy and governmental affairs issues.
Brian graduated magna cum laude from the George Mason University School of Law. He received his B.A. from Boston College, where he graduated magna cum laude and Phi Beta Kappa.